ARTICLE | Politics, Policy & Law
Woodcock’s appointment as acting FDA commissioner could be audition for permanent position
Woodcock will focus on COVID-19 response and restoring FDA’s strength as Biden decides if she, Joshua Sharfstein, or someone else should lead the agency
January 16, 2021 2:13 AM UTC
Politics, Policy & Law
When Janet Woodcock moves into the FDA commissioner’s office next week, she will take charge, at least on an acting basis, of an agency that has been pummeled for months. President Donald Trump’s attacks on FDA’s independence and credibility have sapped staff morale while ideologically motivated actions taken by HHS leadership threaten to undermine FDA’s ability to carry out critical tasks. ...